Stonvex
Discover
  • Dashboard
  • World News
  • Stock News
  • Rankings
  • Quant Picks
  • Screener
Markets
  • Heatmap
  • Gainers & Losers
Tools
  • Compare
  • Calendar
  • Community
HomeRankingsScreenerPortfolioCommunity
Stonvex
Log inGet Started
← Back to search

ZWS

Live
Real-time chart · IB-grade AI research · Polygon.io data feed
Set alertSave
  • Overview
  • Financials
  • Filings
  • Short Interest
  • Ownership
  • Ratings
  • Peers
  • Options
  • News
✦
Stonvex AI

ZWS

AI Research Report

Powered by Claude

Ready to analyze ZWS

Runs the full IB-grade framework: Narrative, Reverse DCF, Comps, Sensitivity, and Deal Radar. Takes 20–40 seconds.

Free preview · 3 reports / hour · No sign-up required

Earnings

Next report date, year-over-year trend, and recent quarter history.

Earnings history activates with Polygon. When configured, this panel shows the next report date, consensus EPS/revenue, and the last 4 quarters of actual-vs-estimate.

Quant Grades

6-factor scoring with sector-relative rank. Updated daily.

Quant grades are available for tickers in our scored universe.

Financial statements

Most recent quarterly filings sourced directly from SEC EDGAR.

Financial statements activate with Polygon. The Developer plan includes quarterly and annual filings sourced directly from SEC EDGAR.

Corporate events

Share this analysis

Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.

Stonvex

AI-powered stock research for US equities.

whgksdhr1111@naver.com

Product

  • Rankings
  • Quant Picks
  • Screener
  • Markets
  • Compare
  • Calendar

Company

  • About Stonvex
  • Pricing & Plans
  • Community
  • Help & FAQ
  • Contact Us

Legal

  • Terms of Service
  • Privacy Policy
  • Privacy Consent
  • Disclaimer
  • Notices & Updates

© 2026 Stonvex. All rights reserved.

This site is for informational purposes only. Not investment advice. Past performance does not guarantee future results.

Latest news

Factor Grades

5-factor analysis: Valuation, Growth, Profitability, Momentum, Financial Health.

Zurn Elkay Water Solutions Corp

Zurn Elkay Water Solutions Corp

Building·NEW YORK STOCK EXCHANGE, INC.·US·IPO 2012-03-29
📅 Earnings in 7d (Apr 21)

Factor Grades

View details →
B-
Overall score: 64/100
C
Valuation
B-
Growth
C+
Profitability
B-
Momentum
A-
Financial Health
  • Benzinga·10h ago

    Stifel Maintains Buy on Zurn Elkay Water Solns, Lowers Price Target to $53

    Stifel analyst Nathan Jones maintains Zurn Elkay Water Solns (NYSE:ZWS) with a Buy and lowers the price target from $59 to $53.

  • View all news →
NEW YORK STOCK EXCHANGE, INC.After-hours
Zurn Elkay Water Solutions Corp
Building
$49.35
$-0.26 (-0.52%)
After-hrs · vs prev close $49.61
Open
$49.44
Prev close
$49.61
Day range
$48.83 – $49.88
52W range
$28.58 – $53.17
Mkt cap
$7.54B
P/E
42.0
EPS
$1.16
Beta
1.16

Fundamentals

Valuation
Market Cap
$7.54B
P/E (TTM)
42.01S&P avg ~22
P/S (TTM)
4.91S&P avg ~2.8
P/B
4.85S&P avg ~4.5
P/FCF
26.28S&P avg ~26
EPS (TTM)
$1.16
Book/sh
$9.60
Cash/sh
$1.80
Profitability
Gross Margin
45.10%avg ~45%
Operating Margin
17.04%avg ~15%
Net Margin
11.68%avg ~12%
ROE
12.56%avg ~18%
ROA
7.45%avg ~7%
ROI
9.55%
Payout Ratio
32.27%
FCF/sh
—
Growth & Health
Rev Growth YoY
8.26%
Rev Growth 5Y
24.69%
EPS Growth YoY
26.08%
EPS Growth 5Y
3.80%
Current Ratio
—
Quick Ratio
2.07
Debt/Equity
—
LT Debt/Eq
—
Trading & Dividends
Beta
1.16
52W High
$53.17
52W Low
$28.58
Avg Vol (10D)
838.4K
Avg Vol (3M)
953.2K
Div Yield
0.94%
Div/sh (TTM)
—
Analyst
Buy (15)
Price Performance
5D+9.27%
MTD+10.64%
3M+8.13%
6M+4.91%
YTD+6.71%
1Y+69.96%

Analyst Consensus

Buy
Based on 15 analysts
Period: 2026-04-01
8 Buy (53%)7 Hold (47%)0 Sell (0%)
Rating Distribution
Strong Buy
4
Buy
4
Hold
7
Sell
0
Strong Sell
0
Trend
2026-04
8/7/0
2026-03
8/7/0
2026-02
8/7/0
2026-01
7/6/0

Recent insider activity

View all →
  • 4FORM 4
    Feb 19
  • 4FORM 4
    Feb 19
  • 4FORM 4
    Feb 19
  • 4FORM 4
    Feb 19
  • 4FORM 4
    Feb 19